Ramakrishnan et al. reported that common chemotherapeutic drugs could sensitize tumour cells to CTLs by increasing the permeability of tumour cells to granzyme B via the upregulation of mannose-6-phosphate receptors 99. Here, GZMB is linked to neoplasm.